This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
host species | 334 |
infectious diseases | 311 |
life cycle | 241 |
infl uenza | 201 |
immune response | 183 |
host range | 169 |
infectious disease | 162 |
rna viruses | 159 |
host cell | 155 |
host population | 152 |
influenza virus | 141 |
immune system | 131 |
genetic diversity | 130 |
avian influenza | 130 |
virus infection | 130 |
ebola virus | 124 |
host immune | 114 |
host proteins | 112 |
immune responses | 110 |
new host | 108 |
innate immune | 108 |
public health | 107 |
west nile | 101 |
host cells | 100 |
emerging infectious | 99 |
host defence | 98 |
dna viruses | 96 |
may also | 95 |
species transmission | 91 |
mycobacterium tuberculosis | 91 |
host shifts | 91 |
life cycles | 90 |
gene expression | 88 |
type i | 88 |
viral replication | 88 |
cell surface | 88 |
virus evolution | 87 |
viral infection | 86 |
nile virus | 85 |
virulence factors | 83 |
influenza viruses | 81 |
novel host | 81 |
disease ecology | 80 |
rna virus | 80 |
innate immunity | 79 |
disease emergence | 79 |
amino acid | 77 |
doc id | 76 |
cord uid | 76 |
host evolution | 74 |
virulence evolution | 74 |
defence peptides | 72 |
landscape genetics | 72 |
respiratory syndrome | 72 |
epithelial cells | 72 |
united states | 71 |
acute respiratory | 71 |
herpes simplex | 71 |
fi tness | 70 |
host switching | 70 |
closely related | 69 |
species richness | 67 |
host populations | 66 |
viral infections | 65 |
natural selection | 65 |
viral load | 64 |
viral proteins | 64 |
severe acute | 63 |
pathogen interactions | 63 |
immunodeficiency virus | 62 |
disease transmission | 62 |
positive selection | 60 |
host interactions | 60 |
infectious agents | 60 |
adaptive immune | 59 |
virus replication | 59 |
pathogen transmission | 59 |
simplex virus | 58 |
wild birds | 58 |
respiratory tract | 57 |
human health | 56 |
disease virus | 56 |
adaptive immunity | 54 |
cause disease | 54 |
virus transmission | 54 |
host factors | 54 |
genetic variation | 53 |
lyme disease | 52 |
i interferon | 52 |
host density | 52 |
direct contact | 52 |
virus families | 51 |
cell lines | 50 |
reservoir hosts | 50 |
host specificity | 50 |
affecting humans | 50 |
host body | 50 |
protein interaction | 50 |
human populations | 50 |
emerging viruses | 50 |
evolutionary history | 50 |
human disease | 49 |
highly pathogenic | 49 |
climate change | 48 |
human immunodeficiency | 47 |
infectious agent | 47 |
intermediate host | 47 |
cell culture | 46 |
human genome | 46 |
human host | 45 |
bridge hosts | 45 |
landscape genetic | 45 |
infected cells | 44 |
north america | 44 |
population size | 43 |
large number | 43 |
human population | 43 |
viruses may | 43 |
hemorrhagic fever | 42 |
phylogenetic distance | 42 |
host phylogeny | 41 |
vaccine evolution | 41 |
reservoir host | 41 |
wide range | 41 |
virus host | 41 |
rna polymerase | 41 |
host response | 40 |
escherichia coli | 40 |
new species | 40 |
susceptible host | 40 |
life history | 40 |
reservoir species | 39 |
host immunity | 38 |
population dynamics | 38 |
different species | 38 |
organ tropisms | 38 |
recent studies | 38 |
vaccinia virus | 38 |
infected host | 38 |
animal species | 37 |
protein interactions | 37 |
host switch | 37 |
segmented filamentous | 37 |
virus type | 37 |
dendritic cells | 36 |
cell death | 36 |
viral genome | 36 |
host interaction | 36 |
important role | 36 |
drosophila melanogaster | 36 |
filamentous bacteria | 36 |
nipah virus | 35 |
reactive arthritis | 35 |
bacterial pathogens | 35 |
syndrome coronavirus | 35 |
bridge host | 35 |
human pathogens | 35 |
dengue virus | 35 |
parasite species | 35 |
immune cells | 35 |
antimicrobial activity | 34 |
sars coronavirus | 34 |
viral diseases | 34 |
one host | 34 |
plasma membrane | 34 |
mtb infection | 34 |
disease resistance | 34 |
endogenous retroviruses | 34 |
yellow fever | 34 |
reproductive isolation | 33 |
individual host | 33 |
virus infections | 33 |
phylogenetic analysis | 33 |
selective pressure | 33 |
population density | 33 |
disease dynamics | 33 |
amino acids | 33 |
pathogen species | 33 |
potential host | 33 |
wild primates | 33 |
host protein | 32 |
virus particles | 32 |
even though | 32 |
virus emergence | 32 |
galapagos islands | 32 |
north american | 32 |
susceptible hosts | 32 |
fish gnats | 32 |
viral families | 32 |
emerging pathogens | 32 |
viral pathogens | 32 |
virus disease | 31 |
host shutoff | 31 |
contact rates | 31 |
infected hosts | 31 |
host mrna | 31 |
pseudomonas aeruginosa | 31 |
zika virus | 30 |
environmental factors | 30 |
positively selected | 30 |
pathogenic viruses | 30 |
intermediate hosts | 30 |
bat species | 30 |
uenza virus | 30 |
organ systems | 30 |
will also | 29 |
dilution effect | 29 |
nose syndrome | 29 |
disease risk | 29 |
network analysis | 29 |
vector species | 29 |
immune defenses | 29 |
pathogen spillover | 29 |
resistance mechanisms | 29 |
disease control | 29 |
gene flow | 29 |
virus genome | 29 |
pulmonary syndrome | 29 |
unpublished data | 29 |
host genome | 29 |
infectious bronchitis | 29 |
organ system | 29 |
newcastle disease | 29 |
also known | 29 |
population level | 28 |
drug targets | 28 |
major histocompatibility | 28 |
new world | 28 |
crustacean parasites | 28 |
parasite dynamics | 28 |
fever virus | 28 |
evolutionary biology | 28 |
receptor binding | 28 |
different host | 28 |
target host | 28 |
host damage | 28 |
social behavior | 28 |
virus species | 27 |
stranded rna | 27 |
viral pathogenesis | 27 |
genes involved | 27 |
bacterial infection | 27 |
gene transfer | 27 |
uenza pandemic | 27 |
species may | 27 |
parasite transmission | 27 |
hantavirus pulmonary | 27 |
old world | 27 |
microbial pathogenesis | 27 |
years ago | 27 |
preferential host | 27 |
parasite interactions | 27 |
rabies virus | 27 |
highly conserved | 27 |
host innate | 26 |
high levels | 26 |
domestic animals | 26 |
hong kong | 26 |
genetic material | 26 |
infected individuals | 26 |
invasion threshold | 26 |
inflammatory response | 26 |
mammalian cells | 26 |
new hosts | 26 |
fi rst | 26 |
dna virus | 26 |
genetic structure | 26 |
virulence determinants | 26 |
bird species | 26 |
host shift | 26 |
human cells | 26 |
immune evasion | 26 |
highly virulent | 26 |
toxoplasma gondii | 25 |
case study | 25 |
phylogenetic risk | 25 |
virus family | 25 |
virus may | 25 |
viral genes | 25 |
cell types | 25 |
short term | 25 |
nervous system | 25 |
two species | 25 |
fish lice | 25 |
pathogenic avian | 25 |
human viruses | 25 |
viral sequences | 25 |
natural hosts | 25 |
interaction networks | 25 |
also found | 25 |
parasitic barnacles | 25 |
persistent infections | 25 |
disease spread | 25 |
zoonotic viruses | 25 |
environmental conditions | 25 |
barr virus | 25 |
viral evolution | 24 |
sialic acid | 24 |
recipient host | 24 |
yersinia pestis | 24 |
two different | 24 |
mass spectrometry | 24 |
type fimbriae | 24 |
human protein | 24 |
sindbis virus | 24 |
spanish infl | 24 |
emerging diseases | 24 |
viral gene | 24 |
genetic data | 24 |
recent study | 24 |
host defenses | 24 |
host defense | 24 |
infect humans | 24 |
transmission dynamics | 24 |
cell line | 24 |
biodiversity loss | 23 |
body environment | 23 |
south america | 23 |
mutation rate | 23 |
multiple host | 23 |
high virulence | 23 |
viral disease | 23 |
avian pox | 23 |
molecular evolution | 23 |
host resistance | 23 |
bluetongue virus | 23 |
recent years | 23 |
signaling pathways | 23 |
natural host | 23 |
selective pressures | 23 |
host gene | 23 |
like receptor | 22 |
molecular mimicry | 22 |
encephalitis virus | 22 |
genetic information | 22 |
determine whether | 22 |
trichomonas vaginalis | 22 |
transmission rate | 22 |
internal organs | 22 |
like receptors | 22 |
may provide | 22 |
cleavage site | 22 |
mouse model | 22 |
mosaic virus | 22 |
host genetic | 22 |
human virome | 22 |
single host | 22 |
virus entry | 22 |
sin nombre | 22 |
become infected | 22 |
disease outbreaks | 22 |
surface receptors | 22 |
short linear | 22 |
one species | 22 |
cellular processes | 22 |
bat viruses | 22 |
histocompatibility complex | 22 |
species diversity | 22 |
risk factors | 22 |
mrna degradation | 22 |
host pathways | 22 |
rna interference | 22 |
west africa | 22 |
canine parvovirus | 21 |
future research | 21 |
human transmission | 21 |
selected sites | 21 |
contact via | 21 |
molecular basis | 21 |
salmonella enterica | 21 |
may occur | 21 |
host environment | 21 |
parallel evolution | 21 |
rnai screens | 21 |
viral entry | 21 |
spillover events | 21 |
myxoma virus | 21 |
population structure | 21 |
population genetics | 21 |
metabolic rate | 21 |
blood stages | 21 |
commercial poultry | 21 |
human cytomegalovirus | 21 |
genetic variability | 21 |
systems biology | 21 |
specific pathogens | 21 |
large dna | 21 |
disease vectors | 21 |
tissue tropism | 21 |
human influenza | 21 |
many cases | 21 |
avian leukosis | 21 |
transmission modes | 21 |
maintenance host | 21 |
evolutionary dynamics | 21 |
pathogen dynamics | 21 |
host systems | 21 |
coral reef | 20 |
endogenous viral | 20 |
host susceptibility | 20 |
viral life | 20 |
members affecting | 20 |
alternate hosts | 20 |
williams unpublished | 20 |
host level | 20 |
equine encephalitis | 20 |
stem cells | 20 |
vaccine growth | 20 |
may result | 20 |
burkholderia pseudomallei | 20 |
human proteins | 20 |
blood group | 20 |
helicobacter pylori | 20 |
viral species | 20 |
response framework | 20 |
central africa | 20 |
infection course | 20 |
familial nature | 20 |
new viruses | 20 |
host competence | 20 |
nucleic acid | 20 |
major role | 20 |
natural populations | 20 |
american orthohantaviruses | 20 |
host will | 20 |
viral rna | 20 |
crispr cas | 20 |
central nervous | 20 |
primary tissue | 20 |
host genes | 20 |
antiviral activity | 20 |
monoclonal antibody | 20 |
phylogenetic trees | 20 |
convergent evolution | 20 |
penaeid shrimp | 20 |
binding protein | 20 |
mortality rate | 19 |
population growth | 19 |
well known | 19 |
hepatitis virus | 19 |
may represent | 19 |
parasite population | 19 |
multiple hosts | 19 |
cell receptor | 19 |
evidence suggests | 19 |
microorganism interaction | 19 |
disease management | 19 |
leukemia virus | 19 |
monoclonal antibodies | 19 |
nombre virus | 19 |
may lead | 19 |
class i | 19 |
adaptive evolution | 19 |
reverse genetics | 19 |
new virus | 19 |
conservation biology | 19 |
natural reservoir | 19 |
potential hosts | 19 |
membrane protein | 19 |
drug resistance | 19 |
different types | 19 |
large numbers | 19 |
species barrier | 19 |
pathogen prevalence | 19 |
gut microbiota | 19 |
viral dna | 19 |
new insights | 19 |
linear motifs | 19 |
may help | 19 |
specific host | 19 |
increased virulence | 19 |
red queen | 19 |
transmission events | 19 |
pandemic risk | 19 |
host co | 19 |
much less | 19 |
hiv infection | 19 |
internal organ | 19 |
experimental studies | 19 |
host dna | 18 |
mutation rates | 18 |
blood parasites | 18 |
intestinal tract | 18 |
staphylococcus aureus | 18 |
twentieth century | 18 |
pathogenic bacteria | 18 |
intrinsic fitness | 18 |
many viruses | 18 |
fish isopods | 18 |
low levels | 18 |
first step | 18 |
bacterial infections | 18 |
mouse hepatitis | 18 |
avian cholera | 18 |
viral genomes | 18 |
essential genes | 18 |
causative agent | 18 |
tongue worms | 18 |
case studies | 18 |
recent advances | 18 |
canine distemper | 18 |
bacterial species | 18 |
mathematical models | 18 |
ecology theory | 18 |
secondary tissue | 18 |
new york | 18 |
antimicrobial peptide | 18 |
valley fever | 18 |
wild seabirds | 18 |
drug repurposing | 18 |
th cells | 18 |
external environment | 18 |
host community | 18 |
global health | 18 |
induced disease | 18 |
common ancestor | 18 |
population biology | 18 |
high affinity | 18 |
fruit bats | 18 |
epithelial cell | 18 |
cellular receptor | 17 |
social network | 17 |
virus strains | 17 |
marburg virus | 17 |
pathogen interaction | 17 |
inflammatory bowel | 17 |
measles virus | 17 |
generation sequencing | 17 |
parasites may | 17 |
small molecule | 17 |
wild bird | 17 |
several studies | 17 |
host relationships | 17 |
plasmodium falciparum | 17 |
chikungunya virus | 17 |
definitive host | 17 |
many species | 17 |
single amino | 17 |
spike protein | 17 |
virus interactions | 17 |
parasitic copepods | 17 |
primate species | 17 |
clinical signs | 17 |
avian viruses | 17 |
ns protein | 17 |
endogenous retrovirus | 17 |
protein kinase | 17 |
pattern recognition | 17 |
better understand | 17 |
heparan sulfate | 17 |
viral transmission | 17 |
individual hosts | 17 |
human infectious | 17 |
restriction factors | 17 |
secondary infections | 17 |
see table | 17 |
assortative mating | 17 |
vertebrate hosts | 17 |
fi delity | 17 |
extracellular protein | 17 |
high prevalence | 17 |
successful host | 17 |
another example | 17 |
gene therapy | 17 |
might also | 17 |
viral evasion | 17 |
rift valley | 17 |
viral protein | 17 |
cell tropism | 17 |
viral particles | 17 |
sea lice | 17 |
million years | 17 |
immune function | 17 |
zoonotic pathogens | 17 |
sm cl | 17 |
mouth disease | 17 |
bowel disease | 17 |
human activities | 17 |
parameter values | 16 |
narrow host | 16 |
virus infiltration | 16 |
related viruses | 16 |
rna decay | 16 |
whale lice | 16 |
protein synthesis | 16 |
human beta | 16 |
will likely | 16 |
spillover risk | 16 |
virus spread | 16 |
original host | 16 |
host tropism | 16 |
animal health | 16 |
basic reproductive | 16 |
host anti | 16 |
protein microarrays | 16 |
borne zoonotic | 16 |
emerging infections | 16 |
target microorganisms | 16 |
surface receptor | 16 |
host mortality | 16 |
rnai screen | 16 |
wildlife disease | 16 |
evolutionary ecology | 16 |
emergence events | 16 |
animal models | 16 |
hendra virus | 16 |
mrna decay | 16 |
virus will | 16 |
different viruses | 16 |
comparative analysis | 16 |
identify host | 16 |
wildlife populations | 16 |
cystic fibrosis | 16 |
zoonotic diseases | 16 |
virus life | 16 |
high mortality | 16 |
emerging virus | 16 |
also identified | 16 |
transmission occurs | 16 |
viruses transmitted | 16 |
vaccine virus | 16 |
bronchitis virus | 16 |
will depend | 16 |
leukosis virus | 16 |
clinical trials | 16 |
cell proliferation | 16 |
cycle stages | 16 |
virus populations | 16 |
transmission among | 16 |
genome sequence | 16 |
rna elements | 16 |
new resistance | 16 |
natural history | 16 |
environmental survival | 16 |
total number | 16 |
authors declare | 16 |
virus environmental | 16 |
interaction network | 16 |
th century | 16 |
fitness effects | 16 |
body infiltration | 16 |
antimicrobial peptides | 15 |
course productive | 15 |
virion assembly | 15 |
successful infection | 15 |
population sizes | 15 |
host cytosolic | 15 |
human diseases | 15 |
factors affecting | 15 |
may play | 15 |
dn ds | 15 |
molecular characterization | 15 |
viral diversity | 15 |
drug discovery | 15 |
host rna | 15 |
epidemiological models | 15 |
severe disease | 15 |
pathogen community | 15 |
high throughput | 15 |
molecular biology | 15 |
large proportion | 15 |
data sets | 15 |
viral mrna | 15 |
current knowledge | 15 |
mammalian host | 15 |
viral elements | 15 |
broad range | 15 |
global trends | 15 |
stomatitis virus | 15 |
better understanding | 15 |
may act | 15 |
wide variety | 15 |
emerging disease | 15 |
pandemic influenza | 15 |
biological control | 15 |
enveloped viruses | 15 |
dna replication | 15 |
high level | 15 |
theoretical models | 15 |
tuberculosis infection | 15 |
host infection | 15 |
simian immunodeficiency | 15 |
avian species | 15 |
experimental infections | 15 |
interferon induction | 15 |
diarrhea virus | 15 |
reverse transcriptase | 15 |
genetic analysis | 15 |
cysteine proteases | 15 |
vesicular stomatitis | 15 |
middle east | 15 |
enteric pathogens | 15 |
novel hosts | 15 |
like virus | 15 |
bat populations | 15 |
hosts may | 15 |
infection period | 15 |
population genetic | 15 |
pathogen virulence | 15 |
resource limitation | 15 |
genetically engineered | 15 |
transcription factor | 15 |
genetic engineering | 15 |
will provide | 15 |
molecular genetic | 14 |
biological processes | 14 |
free living | 14 |
migratory birds | 14 |
intracellular pathogens | 14 |
may cause | 14 |
four virus | 14 |
avoids host | 14 |
virus population | 14 |
theoretical concepts | 14 |
competent hosts | 14 |
ecological relationships | 14 |
intervention strategies | 14 |
human gut | 14 |
vertical transmission | 14 |
rodent hosts | 14 |
animal rule | 14 |
structural proteins | 14 |
risk assessment | 14 |
target population | 14 |
vast majority | 14 |
microbial species | 14 |
gut microbiome | 14 |
intracellular survival | 14 |
animal model | 14 |
lassa virus | 14 |
binding domain | 14 |
transmission function | 14 |
brown bats | 14 |
seabird species | 14 |
human evolution | 14 |
sequence data | 14 |
viral diarrhea | 14 |
larval stages | 14 |
zoonotic disease | 14 |
crucial role | 14 |
membrane proteins | 14 |
antigen presentation | 14 |
two main | 14 |
community ecology | 14 |
virus virulence | 14 |
receptor specificity | 14 |
mammalian hosts | 14 |
stranded dna | 14 |
spatial scales | 14 |
disease network | 14 |
signifi cant | 14 |
converting enzyme | 14 |
avian malaria | 14 |
genera affecting | 14 |
south africa | 14 |
reproductive success | 14 |
virus isolated | 14 |
target hosts | 14 |
final host | 14 |
phylogenetic analyses | 14 |
may serve | 14 |
endangered species | 14 |
wild populations | 14 |
microbe interactions | 14 |
secretion system | 14 |
distemper virus | 14 |
related species | 14 |
role played | 14 |
reef fishes | 14 |
accommodation platforms | 14 |
will allow | 14 |
wide rnai | 14 |
combination therapy | 14 |
therapeutic intervention | 14 |
widely used | 14 |
sequence similarity | 14 |
available data | 14 |
signal peptide | 14 |
infection prevalence | 14 |
broad host | 14 |
mammalian species | 14 |
ixodes uriae | 14 |
bovine viral | 14 |
host genomes | 14 |
small number | 14 |
transmission routes | 14 |
salmonella typhimurium | 14 |
host may | 13 |
hippoboscid flies | 13 |
synthetic biology | 13 |
hosts will | 13 |
host targets | 13 |
competing interests | 13 |
life histories | 13 |
zoonotic transmission | 13 |
human infections | 13 |
envelope protein | 13 |
see also | 13 |
gastrointestinal tract | 13 |
disease vector | 13 |
gene products | 13 |
adjacency matrix | 13 |
uenza viruses | 13 |
host cellular | 13 |
contaminated water | 13 |
complex interactions | 13 |
parasite virulence | 13 |
potential role | 13 |
adaptive landscape | 13 |
virus genomic | 13 |
th cell | 13 |
infection may | 13 |
induced host | 13 |
chronic infections | 13 |
neutrophil defensins | 13 |
see chapter | 13 |
molecular characteristics | 13 |
dna polymerase | 13 |
early stages | 13 |
antiviral drugs | 13 |
reproductive number | 13 |
empirical data | 13 |
another host | 13 |
target cells | 13 |
cell entry | 13 |
recombinant vector | 13 |
previously unknown | 13 |
antimicrobial resistance | 13 |
body size | 13 |
replication within | 13 |
arms race | 13 |
interaction data | 13 |
eukaryotic dna | 13 |
community similarity | 13 |
viral lineages | 13 |
creative commons | 13 |
host jumping | 13 |
specific pathogen | 13 |
infection risk | 13 |
high mutation | 13 |
seabird populations | 13 |
certain viruses | 13 |
time period | 13 |
infectious virus | 13 |
urogenital tract | 13 |
nonhuman primates | 13 |
new zealand | 13 |
take place | 13 |
supporting information | 13 |
intestinal epithelial | 13 |
dengue fever | 13 |
accommodation sector | 13 |
virus must | 13 |
growth rate | 13 |
francisella tularensis | 13 |
survival rate | 13 |
naturally limited | 13 |
host responses | 13 |
borne diseases | 13 |
bats may | 13 |
rapid evolution | 13 |
least one | 13 |
herd immunity | 13 |
incubation period | 13 |
surface proteins | 13 |
protein microarray | 13 |
comparative analyses | 13 |
new pathogens | 13 |
host jump | 13 |
juvenile stages | 13 |
dendritic cell | 13 |
qualitative research | 13 |
transmission may | 13 |
infections caused | 13 |
genetic changes | 13 |
host contact | 13 |
human endogenous | 13 |
virulence factor | 13 |
virus particle | 13 |
intestinal epithelium | 13 |
like viruses | 13 |
host jumps | 13 |
bird populations | 13 |
new infections | 13 |
indirect contact | 13 |
corona virus | 13 |
aspergillus fumigatus | 12 |
host diversity | 12 |
host ranges | 12 |
different stages | 12 |
many parasites | 12 |
currently available | 12 |
evolutionary relationships | 12 |
previously described | 12 |
signaling pathway | 12 |
cytosolic surveillance | 12 |
less likely | 12 |
community composition | 12 |
protein complexes | 12 |
genetic studies | 12 |
east respiratory | 12 |
evolutionary theory | 12 |
messenger rna | 12 |
infection severity | 12 |
disease process | 12 |
upper respiratory | 12 |
small intestine | 12 |
i ifn | 12 |
temperate phage | 12 |
host genotypes | 12 |
also show | 12 |
maternity colonies | 12 |
pathogens may | 12 |
genome sequencing | 12 |
newly emerging | 12 |
ecological factors | 12 |
screen identifies | 12 |
model systems | 12 |
long periods | 12 |
directed therapies | 12 |
haemorrhagic fever | 12 |
conceptual framework | 12 |
evolutionary biologists | 12 |
high risk | 12 |
higher virulence | 12 |
plant viruses | 12 |
coxiella burnetii | 12 |
fungal pathogens | 12 |
swine fever | 12 |
body condition | 12 |
zoonotic dis | 12 |
host transmission | 12 |
may become | 12 |
mammalian viruses | 12 |
different strains | 12 |
larval stage | 12 |
global spread | 12 |
uenza pandemics | 12 |
cell receptors | 12 |
close contact | 12 |
among hosts | 12 |
major human | 12 |
parasite risk | 12 |
genome sequences | 12 |
infected cell | 12 |
immune systems | 12 |
recipient hosts | 12 |
virus protein | 12 |
relatively low | 12 |
among individuals | 12 |
pathogen spread | 12 |
therapeutic strategies | 12 |
defenses avoids | 12 |
clementsian structure | 12 |
human pathogen | 12 |
viruses belonging | 12 |
starting point | 12 |
vice versa | 12 |
particular virus | 12 |
sexually transmitted | 12 |
geographic range | 12 |
immunomodulatory properties | 12 |
environmental changes | 12 |
immune status | 12 |
life strategy | 12 |
long time | 12 |
poorly understood | 12 |
experimental infection | 12 |
per se | 12 |
bursal disease | 12 |
enterica serovar | 12 |
tobacco mosaic | 12 |
phylogenetic tree | 12 |
infectious bursal | 12 |
social networks | 12 |
feather mites | 12 |
recent emergence | 12 |
interferon response | 12 |
naturally occurring | 12 |
target populations | 12 |
two host | 12 |
new viral | 12 |
adult females | 12 |
syndrome virus | 12 |
management strategies | 12 |
molecular mechanisms | 12 |
commensal bacteria | 12 |
intracellular offspring | 12 |
mucus layer | 12 |
coronavirus nsp | 12 |
nucleotide sequences | 12 |
first time | 12 |
purifying selection | 12 |
threshold model | 12 |
two decades | 12 |
mtb immunity | 12 |
several viruses | 12 |
japanese encephalitis | 12 |
autoimmune disease | 12 |
predator transfer | 12 |
term renting | 12 |
many host | 12 |
fi nd | 12 |
genetically diverse | 12 |
immune surveillance | 12 |
aedes aegypti | 12 |
provide new | 12 |
respiratory secretions | 12 |
zoonotic potential | 12 |
point mutations | 11 |
body temperature | 11 |
viruses appear | 11 |
haploid cell | 11 |
bacillus anthracis | 11 |
evolutionary genetics | 11 |
candida albicans | 11 |
respiratory distress | 11 |
anchor worms | 11 |
genetically modified | 11 |
disease pathogenesis | 11 |
major impact | 11 |
infectious contacts | 11 |
become established | 11 |
selection pressure | 11 |
new disease | 11 |
sample sizes | 11 |
two new | 11 |
host phylogenies | 11 |
outer membrane | 11 |
endothelial cells | 11 |
community structure | 11 |
viral ecology | 11 |
host switches | 11 |
essential host | 11 |
may increase | 11 |
baculovirus penaei | 11 |
pathogen systems | 11 |
indian ocean | 11 |
respiratory disease | 11 |
viral mutation | 11 |
evolutionary change | 11 |
evolutionary histories | 11 |
selective advantage | 11 |
human neutrophil | 11 |
viral adaptation | 11 |
evolutionary analysis | 11 |
host abundance | 11 |
humans seem | 11 |
associated herpesvirus | 11 |
evidence indicates | 11 |
van riper | 11 |
mhc class | 11 |
drug target | 11 |
studies suggest | 11 |
diseases caused | 11 |
directly transmitted | 11 |
south american | 11 |
electron microscopy | 11 |
may facilitate | 11 |
breeding season | 11 |
larval parasitic | 11 |
virus rna | 11 |
endogenous retroviral | 11 |
every year | 11 |
small mammals | 11 |
small molecules | 11 |
higher levels | 11 |
viral community | 11 |
multiple viruses | 11 |
dependent rna | 11 |
genetic tools | 11 |
body fashion | 11 |
gill stages | 11 |
feature matrix | 11 |
onward transmission | 11 |
range expansion | 11 |
fever viruses | 11 |
viral envelope | 11 |
viruses tend | 11 |
relatively large | 11 |
rodent species | 11 |
immune complex | 11 |
trichomonas gallinae | 11 |
inflammatory cytokines | 11 |
persistently infected | 11 |
primate host | 11 |
maintenance function | 11 |
given host | 11 |
polymerase chain | 11 |
novel human | 11 |
common eiders | 11 |
bacterial proteins | 11 |
aedes taeniorhynchus | 11 |
animal viruses | 11 |
rna degradation | 11 |
virulent strains | 11 |
biothreat pathogens | 11 |
virion host | 11 |
high rates | 11 |
animal hosts | 11 |
human primates | 11 |
reticuloendotheliosis virus | 11 |
particularly important | 11 |
infection dynamics | 11 |
galapagos archipelago | 11 |
transmission within | 11 |
immune complexes | 11 |
systematic review | 11 |
sampling effort | 11 |
experimental evidence | 11 |
chain reaction | 11 |
well studied | 11 |
biomedical research | 11 |
vaccine development | 11 |
spectrum antiviral | 11 |
population centers | 11 |
host death | 11 |
therapeutic targets | 11 |
host system | 11 |
intrinsically disordered | 11 |
campylobacter jejuni | 11 |
animal genomes | 11 |
supplementary table | 11 |
cell differentiation | 11 |
metabolic network | 11 |
high diversity | 11 |
indirect transmission | 11 |
million people | 11 |
ibv particles | 11 |
sequence analysis | 11 |
human interactome | 11 |
whole genome | 11 |
mechanisms underlying | 11 |
within hosts | 11 |
also present | 11 |
sensing pathways | 11 |
living organisms | 11 |
high concentrations | 11 |
least two | 11 |
parasite burden | 11 |
may contribute | 11 |
ubiquitin system | 11 |
fitness advantage | 11 |
developmental stages | 11 |
populations may | 11 |
mhc genes | 11 |
generation times | 11 |
manca juvenile | 11 |
pathogenic microorganisms | 11 |
emerging zoonotic | 11 |
viral genetic | 10 |
clostridium difficile | 10 |
ross river | 10 |
near future | 10 |
much higher | 10 |
wild animals | 10 |
host tissues | 10 |
also possible | 10 |
alimentary tract | 10 |
geographical distribution | 10 |
parasite diversity | 10 |
marine anchor | 10 |
protein sequences | 10 |
borrelia burgdorferi | 10 |
vertebrate host | 10 |
fi eld | 10 |
replication strategy | 10 |
new diseases | 10 |
natural killer | 10 |
cell injury | 10 |
may reduce | 10 |
western africa | 10 |
membrane trafficking | 10 |
often used | 10 |
bat poxviruses | 10 |
murine leukemia | 10 |
virus genomes | 10 |
also appear | 10 |
two distinct | 10 |
vaccine antigen | 10 |
host receptor | 10 |
three different | 10 |
sphaerospora molnari | 10 |
crisis management | 10 |
puerto rico | 10 |
gel electrophoresis | 10 |
widely distributed | 10 |
plant rna | 10 |
dependent transmission | 10 |
successful establishment | 10 |
infected mice | 10 |
dientamoeba fragilis | 10 |
ct min | 10 |
bacterial surface | 10 |
capsid protein | 10 |
egg production | 10 |
real world | 10 |
spatial distribution | 10 |
african swine | 10 |
multihost rna | 10 |
different hosts | 10 |
common carp | 10 |
legionella pneumophila | 10 |
polymerase ii | 10 |
target cell | 10 |
viral receptors | 10 |
table i | 10 |
acid substitution | 10 |
virus receptor | 10 |
ct max | 10 |
species belonging | 10 |
evolutionary relationship | 10 |
may include | 10 |
severity level | 10 |
living organism | 10 |
host phylogenetic | 10 |
may therefore | 10 |
signifi cance | 10 |
defense mechanisms | 10 |
borne viruses | 10 |
feline infectious | 10 |
viral loads | 10 |
human cell | 10 |
bodily fluids | 10 |
human adenovirus | 10 |
replication fidelity | 10 |
pathogen communities | 10 |
negative bacteria | 10 |
associated virus | 10 |
type iii | 10 |
human macrophages | 10 |
epidemic diseases | 10 |
experimentally infected | 10 |
sexual reproduction | 10 |
national institute | 10 |
molecular determinants | 10 |
transferrin receptor | 10 |
bacterial virulence | 10 |
disease progression | 10 |
heat shock | 10 |
infection will | 10 |
two viruses | 10 |
extracellular matrix | 10 |
host reservoir | 10 |
multiple species | 10 |
lassa fever | 10 |
shock protein | 10 |
diversity within | 10 |
via aerosols | 10 |
lung epithelial | 10 |
will help | 10 |
also play | 10 |
viruses infecting | 10 |
litopenaeus vannamei | 10 |
immune recognition | 10 |
disease systems | 10 |
ubiquitin ligase | 10 |
parasite fitness | 10 |
cytokine production | 10 |
lower respiratory | 10 |
fossil record | 10 |
largely unknown | 10 |
susceptible individuals | 10 |
viral vectors | 10 |
ibd co | 10 |
binding properties | 10 |
mast cells | 10 |
exceptional virulence | 10 |
mrna turnover | 10 |
provide information | 10 |
direct transmission | 10 |
mortality rates | 10 |
sigmoidal model | 10 |
dipeptidyl peptidase | 10 |
pseudoalcaligenes era | 10 |
evolutionary trade | 10 |
persistent infection | 10 |
factors influencing | 10 |
model host | 10 |
also may | 10 |
airborne transmission | 10 |
may make | 10 |
essential role | 10 |
pathogen sharing | 10 |
small populations | 10 |
significantly higher | 10 |
host ecology | 10 |
nucleic acids | 10 |
also occur | 10 |
surface molecules | 10 |
years later | 10 |
management outcomes | 10 |
eukaryotic viruses | 10 |
cell membrane | 10 |
virus variants | 10 |
range mutants | 10 |
one hand | 10 |
host factor | 10 |
relationships among | 10 |
switching events | 10 |
vector control | 10 |
microbial virulence | 10 |
sea turtles | 10 |
among species | 10 |
results suggest | 10 |
experimental evolution | 10 |
human infection | 10 |
shrimp aquaculture | 10 |
malaria parasites | 10 |
disease processes | 10 |
signifi cantly | 10 |
functional characteristics | 10 |
antibiotic treatment | 10 |
viral quasispecies | 10 |
low genetic | 10 |
negative effects | 10 |
pea crab | 10 |
body fluids | 10 |
proteomic analysis | 10 |
infection cycle | 10 |
transmission pathways | 10 |
per year | 10 |
host individuals | 10 |
first two | 10 |
species pathogen | 10 |
will continue | 10 |
commonly used | 10 |
virus ecology | 10 |
novel coronavirus | 10 |
molecular techniques | 10 |
regulatory machinery | 10 |
infectious peritonitis | 10 |
random structures | 10 |
big brown | 10 |
induce host | 10 |
end hosts | 10 |
salivary glands | 10 |
binding partners | 10 |
mucosal surfaces | 10 |
persistent viruses | 10 |
phylogenetic relationships | 10 |
demographic groups | 10 |
colony size | 10 |
molecular epidemiology | 10 |
habitat fragmentation | 10 |
allow us | 9 |
infecting immune | 9 |
poxvirus infections | 9 |
rodent populations | 9 |
antiviral therapy | 9 |
atypically pathogenic | 9 |
one virus | 9 |
host social | 9 |
immune receptors | 9 |
avian hosts | 9 |
genes required | 9 |
vector vaccines | 9 |
therapeutic agents | 9 |
potential bridge | 9 |
death rate | 9 |
multiple viral | 9 |
exponential model | 9 |
animal virus | 9 |
mediated immunity | 9 |
cells may | 9 |
peromyscus maniculatus | 9 |
phosphate dehydrogenase | 9 |
clinical samples | 9 |
determining whether | 9 |
ciency virus | 9 |
great apes | 9 |
nph distance | 9 |
mononuclear cells | 9 |
particular host | 9 |
coat protein | 9 |
carbon metabolism | 9 |
parasite genotypes | 9 |
white shrimp | 9 |
many years | 9 |
also shown | 9 |
increasing number | 9 |
million deaths | 9 |
containing proteins | 9 |
various viruses | 9 |
relative humidity | 9 |
different virus | 9 |
information regarding | 9 |
rates among | 9 |
virulence will | 9 |
transmission ecology | 9 |
seem naturally | 9 |
also detected | 9 |
embryonic stem | 9 |
wider range | 9 |
one study | 9 |
nsp protein | 9 |
identified using | 9 |
among different | 9 |
highly expressed | 9 |
virus shedding | 9 |
taken together | 9 |
complex rebrooding | 9 |
fusion dynamics | 9 |
source host | 9 |
fecally contaminated | 9 |
dynamic equilibrium | 9 |
parainfluenza virus | 9 |
various host | 9 |
sialic acids | 9 |
infection rates | 9 |
causing disease | 9 |
see chap | 9 |
symbiotic relationships | 9 |
plant pathogens | 9 |
remains unclear | 9 |
virus persistence | 9 |
several recent | 9 |
host genotype | 9 |
pathogen characteristics | 9 |
lymphoid tissue | 9 |
leukemia viruses | 9 |
phylogenetic studies | 9 |
human hosts | 9 |
protein coding | 9 |
retroviral elements | 9 |
rna replication | 9 |
sense rna | 9 |
genes encoding | 9 |
antisense rna | 9 |
vaccine efficacy | 9 |
binding site | 9 |
mtb interactions | 9 |
clinical disease | 9 |
epidemic risk | 9 |
recent evidence | 9 |
brood pouch | 9 |
sm mp | 9 |
rna genomes | 9 |
hcps cases | 9 |
similar results | 9 |
infected macrophages | 9 |
data analysis | 9 |
cell infection | 9 |
purified ibv | 9 |
demographic group | 9 |
molecular level | 9 |
coding genes | 9 |
syringae pv | 9 |
species affecting | 9 |
virus isolates | 9 |
western europe | 9 |
host molecular | 9 |
natural virus | 9 |
wild rodents | 9 |
binding proteins | 9 |
phylogenetic distances | 9 |
throughput sequencing | 9 |
borne disease | 9 |
also used | 9 |
well documented | 9 |
approach may | 9 |
necrosis factor | 9 |
viral metacommunities | 9 |
animal populations | 9 |
peromyscus leucopus | 9 |
spatial genetic | 9 |
immune defences | 9 |
primate hosts | 9 |
river virus | 9 |
chronic wasting | 9 |
will result | 9 |
competent host | 9 |
relatively little | 9 |
horizontal gene | 9 |
endoplasmic reticulum | 9 |
threatened species | 9 |
hiv aids | 9 |
dependent manner | 9 |
including humans | 9 |
reverse transcription | 9 |
viral population | 9 |
metazoan parasites | 9 |
infiltration score | 9 |
pathogen infection | 9 |
evolutionary potential | 9 |
may reveal | 9 |
mass extinctions | 9 |
often associated | 9 |
dna sequences | 9 |
rainbow trout | 9 |
mycobacterial infection | 9 |
may require | 9 |
tritrichomonas foetus | 9 |
see supplementary | 9 |
complete life | 9 |
virus vaccine | 9 |
right panel | 9 |
viruses also | 9 |
iii secretion | 9 |
rapid viral | 9 |
arthropod vectors | 9 |
extracellular host | 9 |
human ace | 9 |
resistance genes | 9 |
several mechanisms | 9 |
envelope glycoprotein | 9 |
different ways | 9 |
may allow | 9 |
yersinia enterocolitica | 9 |
life strategies | 9 |
definitive hosts | 9 |
several different | 9 |
jelly parasitoids | 9 |
prone replication | 9 |
oxygen species | 9 |
viral persistence | 9 |
poorly competent | 9 |
average number | 9 |
cassava mosaic | 9 |
reactive oxygen | 9 |
host processes | 9 |
health organization | 9 |
analysis reveals | 9 |
parasite systems | 9 |
sox targeting | 9 |
immune defense | 9 |
interspecies transmission | 9 |
ecological niche | 9 |
replicate within | 9 |
drosophila cells | 9 |
total host | 9 |
chicken eggs | 9 |
may reflect | 9 |
narrowed host | 9 |
susceptible species | 9 |
crossspecies transmission | 9 |
virus vaccines | 9 |
world health | 9 |
domestic animal | 9 |
natural reservoirs | 9 |
humans may | 9 |
culex quinquefasciatus | 9 |
leaf curl | 9 |
host distribution | 9 |
biothreat agents | 9 |
recent work | 9 |
wasting disease | 9 |
interferon production | 9 |
examples include | 9 |
contact networks | 9 |
economically important | 9 |
peptide peptidase | 9 |
contact rate | 9 |
definition panel | 9 |
antibody therapy | 9 |
biol doi | 9 |
rna segments | 9 |
seabird ticks | 9 |
predictive framework | 9 |
disease agents | 9 |
immunodefi ciency | 9 |
spatial scale | 9 |
based approach | 9 |
group antigen | 9 |
live attenuated | 9 |
xx xx | 9 |
virus organ | 9 |
high density | 9 |
genetic distance | 9 |
pathogen genetic | 8 |
strong evidence | 8 |
species jumps | 8 |
dsdna viruses | 8 |
seems clear | 8 |
direct life | 8 |
cell response | 8 |
new genetic | 8 |
wound healing | 8 |
hepatocellular carcinoma | 8 |
study demonstrated | 8 |
increased susceptibility | 8 |
per host | 8 |
genomic characterization | 8 |
queen hypothesis | 8 |
infected humans | 8 |
present study | 8 |
nipah viruses | 8 |
farm animals | 8 |
acute infection | 8 |
many studies | 8 |
extracellular proteins | 8 |
monte carlo | 8 |
next generation | 8 |
help explain | 8 |
distress syndrome | 8 |
dna synthesis | 8 |
human herpesvirus | 8 |
seabird colonies | 8 |
evolutionary processes | 8 |
resistance gene | 8 |
shallow nodes | 8 |
allee effect | 8 |
virus strain | 8 |
mediated killing | 8 |
gene ontology | 8 |
genetic conflicts | 8 |
std fimbriae | 8 |
mutations responsible | 8 |
direct evidence | 8 |
early detection | 8 |
genetic drift | 8 |
southeast asia | 8 |
fusion protein | 8 |
respiratory infections | 8 |
must also | 8 |
relatively well | 8 |
social thermoregulation | 8 |
embryonated chicken | 8 |
long evolutionary | 8 |
living species | 8 |
parasite infection | 8 |
cellular immune | 8 |
many hosts | 8 |
high rate | 8 |
binding affinity | 8 |
evasion strategies | 8 |
cymothoid isopod | 8 |
viral pathogen | 8 |
disease ecologists | 8 |
intracellular pathogen | 8 |
virus glycoprotein | 8 |
zoonotic infections | 8 |
cell bioenergetics | 8 |
lower virulence | 8 |
microorganism interactions | 8 |
viral immune | 8 |
copepodid stages | 8 |
persistent viral | 8 |
became infected | 8 |
nk cells | 8 |
type virus | 8 |
latent state | 8 |
group size | 8 |
specific cell | 8 |
diverse host | 8 |
immune modulation | 8 |
given time | 8 |
published studies | 8 |
analysis revealed | 8 |
mammalian genomes | 8 |
class ii | 8 |
immune signaling | 8 |
infections may | 8 |
african wild | 8 |
data collection | 8 |
basic amino | 8 |
microbe disease | 8 |
cathepsin ls | 8 |
fi ttest | 8 |
extinction rates | 8 |
single nucleotide | 8 |
viruses use | 8 |
key role | 8 |
also showed | 8 |
homologous recombination | 8 |
borne transmission | 8 |
virus fitness | 8 |
based methods | 8 |
early stage | 8 |
genetic characterization | 8 |
model organisms | 8 |
via host | 8 |
little evidence | 8 |
viral distribution | 8 |
conservation medicine | 8 |
virus groups | 8 |
san cristobal | 8 |
group selection | 8 |
human cases | 8 |
surface glycoproteins | 8 |
world primates | 8 |
disease outbreak | 8 |
shed light | 8 |
high host | 8 |
bronchitis particles | 8 |
surface protein | 8 |
symbiotic relationship | 8 |
open reading | 8 |
mainland ecuador | 8 |
microbial diversity | 8 |
venezuelan equine | 8 |
critical role | 8 |
motif discovery | 8 |
also associated | 8 |
two major | 8 |
alveolar macrophages | 8 |
transmission event | 8 |
recognition receptors | 8 |
different subtypes | 8 |
recent developments | 8 |
active site | 8 |
defective interfering | 8 |
cell adhesion | 8 |
virus proteins | 8 |
human respiratory | 8 |
natural resistance | 8 |
maintenance hosts | 8 |
climatic conditions | 8 |
phylogenetic signal | 8 |
using host | 8 |
proteins may | 8 |
marine fishes | 8 |
biological diversity | 8 |
epithelial modes | 8 |
sign epistasis | 8 |
sfb genomes | 8 |
antiviral agents | 8 |
human monocytes | 8 |
cryptic isopods | 8 |
host relationship | 8 |
across different | 8 |
relative frequency | 8 |
social organization | 8 |
pathogen emergence | 8 |
target species | 8 |
less competent | 8 |
science foundation | 8 |
limited number | 8 |
among host | 8 |
infect human | 8 |
eukaryotic cells | 8 |
summary statistics | 8 |
yellow leaf | 8 |
variola virus | 8 |
dwarf males | 8 |
wild ducks | 8 |
human cathelicidin | 8 |
family members | 8 |
infecting humans | 8 |
identifi cation | 8 |
family retroviridae | 8 |
ecological adaptation | 8 |
myotis lucifugus | 8 |
supplementary material | 8 |
disease susceptibility | 8 |
influenza pandemic | 8 |
little brown | 8 |
like coronaviruses | 8 |
several host | 8 |
antiviral drug | 8 |
santa cruz | 8 |
rna viral | 8 |
animal host | 8 |
wildlife diseases | 8 |
new life | 8 |
purified virions | 8 |
anthrax toxins | 8 |
novel viruses | 8 |
resistance surfaces | 8 |
viral strains | 8 |
virus genotypes | 8 |
another virus | 8 |
future studies | 8 |
experimental study | 8 |
unclear whether | 8 |
large population | 8 |
human papillomavirus | 8 |
partial immunity | 8 |
basic reproduction | 8 |
distantly related | 8 |
human immunodefi | 8 |
genetic differentiation | 8 |
myeloid cells | 8 |
receptor recognition | 8 |
another species | 8 |
skin lesions | 8 |
host fitness | 8 |
air travel | 8 |
eastern equine | 8 |
global burden | 8 |
landscape features | 8 |
acute infections | 8 |
sequencing technologies | 8 |
less virulent | 8 |
patient cohorts | 8 |
relative importance | 8 |
empirical studies | 8 |
protein regions | 8 |
within species | 8 |
within host | 8 |
drosophila perspective | 8 |
low pathogenic | 8 |
greater number | 8 |
transmission potential | 8 |
highly connected | 8 |
cell membranes | 8 |
endonucleolytic cleavage | 8 |
ace receptor | 8 |
cell activation | 8 |
will become | 8 |
avian diversity | 8 |
well established | 8 |
cross species | 8 |
disease surveillance | 8 |
studies using | 8 |
tissue culture | 8 |
antigenic drift | 8 |
cells expressing | 8 |
potential drug | 8 |
social systems | 8 |
identify compounds | 8 |
genome segments | 8 |
st century | 8 |
host reservoirs | 8 |
high densities | 8 |
host restriction | 8 |
health concern | 8 |
present host | 8 |
digestive tract | 8 |
lymph nodes | 8 |
candidatus arthromitus | 8 |
activated protein | 8 |
infective stage | 8 |
emerging viral | 8 |
parameter selection | 8 |
deer mice | 8 |
sexual selection | 8 |
virulence management | 8 |
poxvirus host | 8 |
selfi sh | 8 |
defi nitions | 8 |
sponge shrimp | 8 |
antibiotic resistance | 8 |
infection rate | 8 |
virus spillover | 8 |
allows us | 8 |
genetic basis | 8 |
genome replication | 8 |
hemorrhagic fevers | 8 |
phage therapy | 8 |
sarcoma virus | 8 |
commonly found | 8 |
give rise | 8 |
many different | 8 |
disease caused | 8 |
efflux pump | 8 |
complete genome | 8 |
reemerging pathogens | 8 |
bat social | 8 |
model organism | 8 |
introduced species | 8 |
andes virus | 8 |
environmental change | 8 |
within populations | 8 |
cellular functions | 8 |
system tropism | 7 |
vaccination strategies | 7 |
chemokine receptor | 7 |
i ifns | 7 |
engineered resistance | 7 |
recent research | 7 |
low virulence | 7 |
human microbiome | 7 |
defi ne | 7 |
virus hemagglutinin | 7 |
sfb colonization | 7 |
landscape epidemiology | 7 |
nitric oxide | 7 |
tasmanian devil | 7 |
big data | 7 |
derived macrophages | 7 |
additional file | 7 |
com scientificreports | 7 |
land use | 7 |
evolutionary time | 7 |
avian retroviruses | 7 |
history strategies | 7 |
rapidly evolving | 7 |
cellular mrna | 7 |
alternative hosts | 7 |
health risk | 7 |
cell screens | 7 |
selective autophagy | 7 |
confidence intervals | 7 |
comparative studies | 7 |
virusinduced disease | 7 |
across species | 7 |
infiltration scores | 7 |
life stage | 7 |
virus gene | 7 |
genome evolution | 7 |
becoming increasingly | 7 |
protein network | 7 |
important factor | 7 |
commensal viruses | 7 |
cell function | 7 |
cgas sting | 7 |
new genus | 7 |
also lead | 7 |
mortality among | 7 |
anchor worm | 7 |
family herpesviridae | 7 |
infectious period | 7 |
infected individual | 7 |
vaccination campaigns | 7 |
susceptible population | 7 |
direct cell | 7 |
animal reservoirs | 7 |
terrestrial mammals | 7 |
highly susceptible | 7 |
host evolutionary | 7 |
posterior probabilities | 7 |
brown chromis | 7 |
performed using | 7 |
viruses must | 7 |
feline calicivirus | 7 |
virus via | 7 |
viral richness | 7 |
interferon receptor | 7 |
mm nacl | 7 |
eppi discovery | 7 |
species infection | 7 |
cytosolic dna | 7 |
horizontal transfer | 7 |
also serve | 7 |
go terms | 7 |
long term | 7 |
domestic birds | 7 |
encephalitis viruses | 7 |
disease viruses | 7 |
aedes albopictus | 7 |
vibrio cholerae | 7 |
novel mechanism | 7 |
host parasite | 7 |
genetically distinct | 7 |
nutritional status | 7 |
continue hosting | 7 |
spatial analysis | 7 |
epidemiological data | 7 |
core cellular | 7 |
novel pathogen | 7 |
graph autoencoder | 7 |
transfer host | 7 |
acquired immunodeficiency | 7 |
virus recombination | 7 |
phylogenomic approach | 7 |
biological conservation | 7 |
least three | 7 |
immune pathways | 7 |
simple rebrooding | 7 |
flying foxes | 7 |
host vector | 7 |
acid changes | 7 |
bacterial pathogen | 7 |
severe infections | 7 |
uninfected hosts | 7 |
direct effects | 7 |
viruses cause | 7 |
coronavirus infection | 7 |
pandemic virus | 7 |
respiratory syncytial | 7 |
ha protein | 7 |
online version | 7 |
immune activation | 7 |
transgenic tobacco | 7 |
fruit bat | 7 |
disease may | 7 |
following exposure | 7 |
mediated resistance | 7 |
interactions among | 7 |
previous studies | 7 |
reduce disease | 7 |
carinii pneumonia | 7 |
protein function | 7 |
parasite genotype | 7 |
putative virus | 7 |
hantavirus infections | 7 |
shifts will | 7 |
previously thought | 7 |
expression analysis | 7 |
four species | 7 |
distributed across | 7 |
maintenance community | 7 |
sm sppl | 7 |
interface mimicry | 7 |
tobacco plants | 7 |
different temperatures | 7 |
newly identified | 7 |
naupliar stages | 7 |
spatial relationships | 7 |
recent progress | 7 |
evolution may | 7 |
proximate host | 7 |
defi ned | 7 |
current understanding | 7 |
body mass | 7 |
host molecules | 7 |
evolutionary process | 7 |
borne pathogens | 7 |
will affect | 7 |
mucosal tissues | 7 |
enteric viruses | 7 |
sea urchins | 7 |
pathogenicity islands | 7 |
new parasite | 7 |
tree topologies | 7 |
another important | 7 |
terrestrial vertebrates | 7 |
environmental persistence | 7 |
also affect | 7 |
droplet nuclei | 7 |
swine influenza | 7 |
remain unknown | 7 |
fitness consequences | 7 |
population densities | 7 |
th responses | 7 |
parasite prevalence | 7 |
national science | 7 |
pathogen surveillance | 7 |
transmitted diseases | 7 |
less severe | 7 |
neutral theory | 7 |
related host | 7 |
factors determining | 7 |
provide evidence | 7 |
great potential | 7 |
viral zoonoses | 7 |
syncytial virus | 7 |
new areas | 7 |
real time | 7 |
direct interaction | 7 |
metacommunity structure | 7 |
human proteome | 7 |
infectious laryngotracheitis | 7 |
antigenic shift | 7 |
productive infection | 7 |
relative expression | 7 |
virus outbreak | 7 |
individual patients | 7 |
geographical area | 7 |
empirical evidence | 7 |
become available | 7 |
serovar typhimurium | 7 |
binding sites | 7 |
rnai screening | 7 |
adaptive response | 7 |
complex life | 7 |
acute disease | 7 |
dna pol | 7 |
resting host | 7 |
species also | 7 |
mouse models | 7 |
diffi cult | 7 |
i suggest | 7 |
rapid spread | 7 |
immunodeficiency viruses | 7 |
wide association | 7 |
cell fusion | 7 |
review see | 7 |
model system | 7 |
hospitality industry | 7 |
past years | 7 |
airway epithelial | 7 |
host movement | 7 |
evidence supporting | 7 |
immunodeficiency syndrome | 7 |
may influence | 7 |
global pandemic | 7 |
blue crab | 7 |
inhibitory receptor | 7 |
virus needs | 7 |
stem cell | 7 |
worldwide distribution | 7 |
directly affect | 7 |
content imaging | 7 |
foamy viruses | 7 |
related virus | 7 |
human immune | 7 |
reproductive rate | 7 |
molecular clock | 7 |
fish host | 7 |
adaptive landscapes | 7 |
host organism | 7 |
large amounts | 7 |
genetic sequence | 7 |
viral spread | 7 |
health implications | 7 |
predict pathogen | 7 |
surveillance pathway | 7 |
peptides might | 7 |
zoonotic viral | 7 |
control strategies | 7 |
bacterial toxins | 7 |
protein composition | 7 |
major cause | 7 |
different spatial | 7 |
increased expression | 7 |
house mice | 7 |
polyacrylamide gel | 7 |
species composition | 7 |
molecular phylogeny | 7 |
one might | 7 |
recently emerged | 7 |
juvenile fish | 7 |
switch probability | 7 |
small genomes | 7 |
protein array | 7 |
plant species | 7 |
evolution within | 7 |
wild dogs | 7 |
increased host | 7 |
viral capsid | 7 |
virus growth | 7 |
class aves | 7 |
group antigens | 7 |
specific virulence | 7 |
pathogen protein | 7 |
short time | 7 |
pathogen evolution | 7 |
may even | 7 |
given pathogen | 7 |
tumor necrosis | 7 |
positive precursor | 7 |
individuals may | 7 |
disease development | 7 |
subsequent infection | 7 |
eptesicus fuscus | 7 |
individual differences | 7 |
evolutionary genomics | 7 |
host preference | 7 |
genes may | 7 |
immune components | 7 |
vaccine strain | 7 |
viral endonucleases | 7 |
optimal virulence | 7 |
relatively small | 7 |
best known | 7 |
new therapeutic | 7 |
domestic mammals | 7 |
transmission involving | 7 |
mass mortality | 7 |
distinct viruses | 7 |
mice lacking | 7 |
mathematical model | 7 |
theoretical work | 7 |
carbohydrate moieties | 7 |
acid residues | 7 |
mammalian virus | 7 |
also help | 7 |
democratic republic | 7 |
naturally infected | 7 |
substitutions per | 7 |
next step | 7 |
targeted gene | 7 |
experimental anti | 7 |
presenting cells | 7 |
adult male | 7 |
genomic data | 7 |
southern africa | 7 |
cellular proteins | 7 |
disease symptoms | 7 |
future directions | 7 |
vaccine design | 7 |
mammalian cell | 7 |
pentatrichomonas hominis | 7 |
family ranking | 7 |
immune mechanisms | 7 |
van baalen | 7 |
host defences | 7 |
gene segments | 7 |
also contribute | 7 |
cell wall | 7 |
livestock viruses | 7 |
immunogenic antigens | 7 |
congo hemorrhagic | 7 |
cell cycle | 7 |
system involvement | 7 |
acid substitutions | 7 |
high replication | 7 |
intact flies | 7 |
microbial threats | 7 |
disease prevention | 7 |
entire life | 7 |
reproduction number | 7 |
male host | 7 |
brown shrimp | 7 |
evolutionary ecologists | 7 |
choriomeningitis virus | 7 |
egyptian fruit | 7 |
emergence potential | 7 |
evolutionary consequences | 7 |
virus addiction | 7 |
inflammatory responses | 7 |
evolutionary perspective | 7 |
interferon system | 7 |
transmembrane domain | 7 |
global distribution | 7 |
biofilm formation | 7 |
antagonistic pleiotropy | 7 |
ecological communities | 7 |
evasion mechanisms | 7 |
protein sequence | 7 |
also provide | 7 |
equine viruses | 7 |
vector viruses | 7 |
mrna translation | 7 |
complex disease | 7 |
inflammatory cytokine | 7 |
recently developed | 7 |
may affect | 7 |
transcriptional profiling | 7 |
necrosis virus | 7 |
host antiviral | 7 |
mechanistic models | 7 |
literature search | 7 |
initial infection | 7 |
antigen levels | 7 |
viral pneumonia | 7 |
mating systems | 7 |
eggs hatch | 7 |
rissa tridactyla | 7 |
one another | 7 |
data available | 7 |
primary host | 7 |
cellular level | 7 |
immune globulin | 7 |
big mass | 7 |
developing countries | 7 |
protozoan parasites | 7 |
surveillance pathways | 7 |
intracellular bacteria | 7 |
rna binding | 7 |
molnari blood | 7 |
autophagy pathway | 7 |
viruses isolated | 7 |
molecular data | 7 |
two hosts | 7 |
selection pressures | 7 |
genetic approaches | 7 |
literature survey | 7 |
footed mouse | 7 |
may well | 7 |
host life | 7 |
special interest | 7 |
family picornaviridae | 7 |
deer mouse | 7 |
mechanisms may | 7 |
metacommunities associated | 7 |
existing drugs | 7 |
specific viral | 7 |
international committee | 7 |
relatively rare | 7 |
one example | 7 |
another mechanism | 7 |
certain host | 7 |
epidemic models | 7 |
molecular patterns | 7 |
world monkeys | 7 |
european rabbits | 7 |
viral interactions | 7 |
tb pathogenesis | 7 |
well understood | 7 |
crystal structure | 7 |
supplementary information | 7 |
linear motif | 7 |
causes disease | 7 |
cov infection | 7 |
ebola outbreak | 7 |
plant virus | 7 |
parasitic infections | 7 |
increased risk | 7 |
accommodation hosts | 7 |
also demonstrated | 7 |
defi nition | 7 |
world orthohantaviruses | 7 |
fibrosis patients | 7 |
protein complex | 7 |
fungal pathogen | 7 |
adult female | 7 |
ng ml | 6 |
authors found | 6 |
bovine tuberculosis | 6 |
new mechanisms | 6 |
species associated | 6 |
novel virus | 6 |
range genes | 6 |
malaria parasite | 6 |
range restriction | 6 |
select agent | 6 |
lung injury | 6 |
infected shrimp | 6 |
transmission via | 6 |
anilocra pomacentri | 6 |
last years | 6 |
mutually exclusive | 6 |
silico analysis | 6 |
increase host | 6 |
three new | 6 |
cell biology | 6 |
commons attribution | 6 |
chronic hepatitis | 6 |
economic losses | 6 |
take advantage | 6 |
peripheral blood | 6 |
epidemiological information | 6 |
observed patterns | 6 |
also cause | 6 |
certain species | 6 |
monkeypox virus | 6 |
genomic rna | 6 |
systematic analysis | 6 |
immune interference | 6 |
species effects | 6 |
gene product | 6 |
highly contagious | 6 |
specific immunity | 6 |
underlying host | 6 |
factors required | 6 |
gene mechanism | 6 |
human coronavirus | 6 |
individual mutations | 6 |
viral antigens | 6 |
host pairs | 6 |
replication cycle | 6 |
much longer | 6 |
mechanisms involved | 6 |
vaccine may | 6 |
mass extinction | 6 |
human monoclonal | 6 |
hard ticks | 6 |
different viral | 6 |
natural settings | 6 |
balancing selection | 6 |
replication proteins | 6 |
antigen expression | 6 |
positive relationship | 6 |
measurement error | 6 |
anilocra chromis | 6 |
personal communication | 6 |
parasitic species | 6 |
fish parasite | 6 |
human skin | 6 |
virulence may | 6 |
human exposure | 6 |
target genes | 6 |
segmented viruses | 6 |
also function | 6 |
tlr pathway | 6 |
host health | 6 |
part due | 6 |
mrna expression | 6 |
global change | 6 |
interactions within | 6 |
last decade | 6 |
among viruses | 6 |
vector transmission | 6 |
parasites will | 6 |
sample size | 6 |
single species | 6 |
closest relatives | 6 |
communicable diseases | 6 |
intracellular replication | 6 |
western hemisphere | 6 |
proteins associated | 6 |
new pathogen | 6 |
hippoboscid fly | 6 |
specific disease | 6 |
environmental variables | 6 |
true parasite | 6 |
simple models | 6 |
viral growth | 6 |
enrichment analysis | 6 |
virulence determinant | 6 |
functional genomics | 6 |
physical contact | 6 |
close proximity | 6 |
host specimens | 6 |
reef fish | 6 |
healthy host | 6 |
targeting element | 6 |
northern europe | 6 |
live viral | 6 |
among wild | 6 |
parasitic isopod | 6 |
natural habitat | 6 |
transmission success | 6 |
moult stages | 6 |
genome size | 6 |
foamy virus | 6 |
pneumocystis pneumonia | 6 |
interacting partners | 6 |
recovery rate | 6 |
control efforts | 6 |
initial conditions | 6 |
surface glycoprotein | 6 |
two models | 6 |
evolutionary epidemiology | 6 |
tick ixodes | 6 |
deep sequencing | 6 |
high viral | 6 |
make use | 6 |
virus ns | 6 |
viruses will | 6 |
horizontal transmission | 6 |
allowed us | 6 |
may explain | 6 |
bat virus | 6 |
viral lineage | 6 |
host tissue | 6 |
bronchoalveolar lavage | 6 |
sendai virus | 6 |
initiation factor | 6 |
transmitted vertically | 6 |
global ecosystem | 6 |
species barriers | 6 |
epidemic dynamics | 6 |
higher diversity | 6 |
tissue damage | 6 |
system may | 6 |
test phage | 6 |
maximum number | 6 |
virus dna | 6 |
uenza strain | 6 |
commercially important | 6 |
thermal tolerance | 6 |
lysis time | 6 |
fitness peak | 6 |
cell recognition | 6 |
geographic areas | 6 |
buffered saline | 6 |
vary widely | 6 |
gel pieces | 6 |
species within | 6 |
host specific | 6 |
also important | 6 |
large scale | 6 |
host type | 6 |
interfering particles | 6 |
metabolic networks | 6 |
hibernating bats | 6 |
true parasites | 6 |
virus group | 6 |
mammal parasite | 6 |
virulence traits | 6 |
study using | 6 |
cell invasion | 6 |
reproductive ratio | 6 |
host group | 6 |
identify genes | 6 |
rgd motif | 6 |
human parainfluenza | 6 |
phylogenetic relatedness | 6 |
humoral immune | 6 |
genetically related | 6 |
adult males | 6 |
scores allocated | 6 |
neutralizing antibodies | 6 |
model selection | 6 |
sickle cell | 6 |
viral sequence | 6 |
biological properties | 6 |
technological advances | 6 |
equine infectious | 6 |
different pathogens | 6 |
entry receptor | 6 |
landscape resistance | 6 |
adenovirus type | 6 |
term evolutionary | 6 |
lymphocytic choriomeningitis | 6 |
environmental determinants | 6 |
rich elements | 6 |
high degree | 6 |
vary across | 6 |
virulent mtb | 6 |
signal peptides | 6 |
tongue worm | 6 |
north atlantic | 6 |
essential protein | 6 |
defence peptide | 6 |
human cd | 6 |
small set | 6 |
significant problems | 6 |
higher temperatures | 6 |
bronchial epithelial | 6 |
new technologies | 6 |
close relationship | 6 |
computational analysis | 6 |
high metabolic | 6 |
channel catfish | 6 |
see sect | 6 |
specific receptors | 6 |
sooty mangabeys | 6 |
parasite survival | 6 |
genetic resistance | 6 |
side effects | 6 |
host inflammatory | 6 |
identified host | 6 |
american white | 6 |
therapeutic target | 6 |
different mechanisms | 6 |